Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Deutsche Boerse AG  >  3SBio Inc. (ADR)    YFK

SummaryQuotesNewsAnalysisCompany 
Business Summary
Engages in research, development, manufacturing and marketing of biopharmaceutical products

3SBio, Inc. engages in the provision of biopharmaceutical business.

It develops, research, manufactures and market biopharmaceutical products which are used in the field of medicine particularly in nephrology, oncology, supportive cancer care, inflammation and infectious diseases.

The company was founded by Jing Lou and Dan Lou in 1993 and is headquartered in Shenyang, China.
Managers
NameAgeSinceTitle
Jing Lou MD, PhD521993Chairman & Chief Executive Officer
Bo Tan CFA, MBA422009Chief Financial Officer, Executive Director & EVP
Yong Fu Chen572011Director-Financial Department
Dong Mei Su, PhD452012Director & Chief Technology Officer
Bin Huang, MBA541993Director & VP-Human Resources
Dong Liu EMBA422014Director
Dong LV402014Non-Executive Director
Tianruo Pu, MBA472014Independent Non-Executive Director
David R. Parkinson, MD642014Independent Non-Executive Director
Jun Ma512014Independent Non-Executive Director
Shareholders
NameShares%
CITIC Private Equity Funds Management Co., Ltd. 712,258,360 28.3%
Jing Lou, MD, PhD 659,367,030 26.2%
Bo Tai 115,549,920 4.59%
Bin Huang 33,919,350 1.35%
Dong Mei Su, PhD 26,403,630 1.05%
HSBC Global Asset Management (Hong Kong) Ltd. 14,285,500 0.57%
Columbia Management Investment Advisers LLC 4,482,000 0.18%
Threadneedle Asset Management Ltd. 2,439,705 0.097%
Newton Investment Management Ltd. 403,000 0.016%
Deutsche Asset Management (UK) Ltd. 305,500 0.012%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Advertisement
Sector Biotechnology & Medical Research
Growth (Revenue) Profitability
SHANGHAI RAAS BLO..
-
ACTELION LTD
MEDIVATION INC
RECEPTOS INC
-
GENMAB A/S
BLUEBIRD BIO INC
ZHONGYUAN UNION C..
-
INTERCEPT PHARMAC..
ULTRAGENYX PHARMA..
-
NEUROCRINE BIOSCI..
TONGHUA DONGBAO P..
JUNO THERAPEUTICS..
HUALAN BIOLOGICAL..
DYAX CORP.
AGIOS PHARMACEUTI..
BEIJING SL PHARMA..
CLOVIS ONCOLOGY I..
RADIUS HEALTH INC
-
CHINA BIOLOGIC PR..
KITE PHARMA INC
Sector Biotechnology & Medical Research
3SBio Inc. (ADR) : Connections
Excel Partner Holdings Ltd.
Taizhou Huan Sheng Investment Management Co., Ltd.
Collected Mind Ltd.
UTStarcom, Inc.
Shenzhen Baishitong Technology Development Co., Ltd.
Shanghai Aoxi Technology Information Consulting Co., Ltd.
Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd.
Ample Harvest Investments Ltd.
Beingmate Group Co. Ltd.
Liaoning Sunshine Bio-Pharmaceutical Co. Ltd.
Zhejiang Sunshine Pharmaceutical Co., Ltd.
Hong Kong Sansheng Ltd.
Mudanjiang Youbo Pharmaceutical Co., Ltd.
Shenzhen Sciprogen Bio-Pharmaceutical Co., Ltd.
Zyngenia, Inc.
Ontario Institute for Cancer Research
Tocagen, Inc.
Liaoning Sunshine Science & Technology Development Co. Ltd.
CFA Institute
The Multiple Myeloma Research Foundation, Inc.
Hongkong Sansheng Medical Ltd.
Multiple Myeloma Research Consortium
Company contact information
3SBio, Inc.
Shenyang Economy & Technology Dev
No. 3 A1, Road 10
Shenyang, Liaoning 110027

Phone : +86.24.2581.1820
Fax : +86.24.2581.1821
Web : www.3sbio.com
© 2015 People , Fundamentals and Ownership